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Introduction: Chronic kidney disease is a medical and economic problem. It affects            
10–13  % of the population in European countries and incidence is increasing with every 
decade of life. The most common cause of kidney failure in patients over 50 years of age is 
associated with 2. type diabetes and hypertension. Chronic kidney disease is associated with 
risk of mortality, hospitalization and decreased quality of life. 
Clinical pharmacist as a specialist in a field of pharmacotherapy collaborates with other health 
professionals to optimize pharmacotherapy. Proactive approach with active prevention of drug 
related problems (DRPs) is preferre. Identification and minimization of drug problems 
together with optimization of pharmacotherapy are the main objectives of clinical pharmacy. 
Where the prerequisite for the detection and resolution of drug problems is not only 
knowledge of pharmacology but also other medical disciplines such as biochemistry, 
microbiology, pathophysiology and epidemiology. 
This work is one of the first publications of this type in the Czech Republic, which reveals a 
review of pharmacotherapy in patients with chronic kidney disease and the integration of a 
pharmacist into a multidisciplinary team 
Aim: To provide the most comprehensive picture of DRPs in patients with chronic kidney 
disease and to show the practical integration of a clinical pharmacist into  
a multidisciplinary team caring for nephrological patients not only in the area of DRPs 
identification and solution but also by therapeutic drug monitoring. We focused on therapeutic 
monitoring of aminoglycosides and vancomycin. We verify the validity of hypotheses that 
therapeutic monitoring of aminoglycosides is a cost-effective and to achieve vancomycin 
target concentrations in dialysis patients, it is essential to give an adequate loading dose.  
Methodology: Prospective clinical analysis at the hospital department, based on theoretical 
assumptions about DRPs from published studies. The following tools were used: PCNE V6.2 
(Pharmaceutical Care Network Europe Foundation) was used to break down the DRPs, for 
therapeutic drug monitoring - MwPharm
® 4.0 pharmacokinetic program, SPSS® Statistics 20 
for Windows statistical data processing. 
Results: The pharmacist evaluated the medication in 1850 hospitalized patients with 1192 
DRPs. The most common drug problem identified in our patient population was the untreated 
indication. It accounted for 27.18% of cases (324 DRPs) of the total number of reported drug 
problems. The second largest group of problems was incorrect dose selection - too low a dose, 
which accounted for 20.81% of cases (248 DRPs). The leading cause of DRPs was drug 
selection 56.80% (N = 677). Therapeutic monitoring of aminoglycosides was performed in 52 
patients. There was no evidence of nephrotoxicity in any patient. The most common problem 
was underdose. From the data of 44 dialysis patients, a formula for calculating the loading 
dose of vancomycin was derived. When calculating the initial dose of vancomycin at the start 
of therapy, the patient's weight and age should be taken into account. Control of the measured 
concentration of vancomycin is also influenced by the time of concentration concentration. 
Conclusion: This work is one of the first publications of this type in the Czech Republic, 
which reveals a review of pharmacotherapy in patients with chronic kidney disease and the 
integration of a pharmacist into a multidisciplinary team. Pharmacotherapeutic monitoring 
should be a common part of clinical practice in patients with polypharmacotherapy and with 
drugs with narrow therapeutic index. 
  
 
